Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Taste transduction,0.8503473654227415,1.740381134116617,0.005291005291005291,0.19779700558131294,0.134,8/26,2.72%,Cacna1c;Asic2;Pde1a;Cacna1a;Adcy8;Gabra2;Gabbr2;Chrm3
prerank,Nicotine addiction,0.8830028126922146,1.7229660296800935,0.009433962264150943,0.12299559991731389,0.158,9/24,2.97%,Gria3;Gabrg3;Gria4;Cacna1a;Grin1;Grin2a;Gabra2;Gria1;Cacna1b
prerank,Ribosome,-0.8901792151383329,-1.6734973443011945,0.0,0.0,0.0,79/125,7.91%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rps3a1;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rpl24;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rpl13;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl17;Mrpl36;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Rps18;Rps15a;Mrpl18;Rps16;Rpl39;Rps14;Rpl22l1;Mrpl14;Rps12;Rpl15;Rpl30;Rpl18;Rpl31;Mrpl23;Rps9;Rpl26;Rpl36;Uba52;Rpl34;Mrps21;Rpl36a;Mrpl9;Rpl35a;Rpl32
prerank,Fluid shear stress and atherosclerosis,-0.8594056024233779,-1.5691904441369373,0.0,0.007495110332782898,0.011,13/76,4.91%,Calm1;Calm2;Hsp90ab1;Actb;Calm3;Rac1;Jun;Gstm5;Actg1;Gstm1;Hsp90aa1;Sumo2;Gstp1
prerank,Mucin type O-glycan biosynthesis,0.8286395084407076,1.555631164143782,0.0365296803652968,0.3534240911909754,0.507,6/17,11.19%,Galnt18;Galnt14;Galnt10;Galntl6;Galnt16;Galnt7
prerank,Necroptosis,-0.85482273362017,-1.5555945010457501,0.0,0.007994784354968426,0.019,13/64,6.85%,Fth1;Hsp90ab1;Slc25a4;Hmgb1;Ppia;Hsp90aa1;Slc25a5;Spata2l;Vdac1;Bax;Ftl1;Glul;Sqstm1
prerank,Estrogen signaling pathway,-0.8461018553248519,-1.5288781854599227,0.0,0.020236797898513827,0.061,10/77,3.21%,Calm1;Calm2;Hsp90ab1;Calm3;Kcnj3;Gnas;Krt10;Jun;Hsp90aa1;Hspa8
prerank,Melanogenesis,-0.8575663465818828,-1.5224986413263693,0.0011507479861910242,0.023184874629408433,0.088,4/51,1.47%,Calm1;Calm2;Calm3;Gnas
prerank,Pertussis,-0.9040105467404506,-1.5080654573518684,0.00125,0.033311601479035106,0.14,5/25,2.89%,Calm1;Calm2;Calm3;Jun;Cfl1
prerank,Oxidative phosphorylation,-0.8090268587927775,-1.5064621463789198,0.0,0.029837677324792873,0.144,59/100,14.35%,Cyc1;Atp6v0c;Atp5b;Ndufa3;Atp6v1d;Ndufa1;Uqcrq;Cox6c;Cox17;Atp6v1a;Ndufs8;Ndufs5;Atp5o;Cox8a;Atp5h;Atp6v1g2;Cox5b;Atp6v0e2;Atp5j;Uqcrb;Ndufs2;Cox7a2l;Atp5d;Cox4i1;Cox6b1;Cox6a1;Cox7c;Ndufa2;Uqcr10;Atp5e;Ndufs7;Ndufa4;Ndufb3;Uqcrc1;Ndufb11;Atp5g2;Ndufb10;Cox5a;Atp6v1f;Cox7a2;Atp5k;Uqcrh;Ndufa13;Atp5g3;Atp5l;Atp5g1;Cox7b;Atp6v0b;Ndufb8;Atp5a1;Uqcr11;Ndufa8;Ndufa7;Ndufv1;Uqcrc2;Ndufc2;Sdhd;Ndufv2;Atp6v1e1
prerank,Parkinson disease,-0.8038618374367208,-1.4956972949185339,0.0,0.03847489970828554,0.203,59/104,14.24%,Ubb;Slc25a4;Cyc1;Atp5b;Ndufa3;Ndufa1;Uqcrq;Park7;Cox6c;Ndufs8;Ndufs5;Atp5o;Cox8a;Atp5h;Slc25a5;Cox5b;Atp5j;Uqcrb;Vdac1;Ndufs2;Cox7a2l;Atp5d;Cox4i1;Cox6b1;Cox6a1;Cox7c;Ndufa2;Uqcr10;Atp5e;Ndufs7;Ndufa4;Ndufb3;Uqcrc1;Ndufb11;Atp5g2;Ndufb10;Cox5a;Ube2j1;Cox7a2;Cycs;Uqcrh;Ndufa13;Atp5g3;Atp5g1;Cox7b;Pink1;Ndufb8;Atp5a1;Uqcr11;Ndufa8;Uba1;Ndufa7;Vdac3;Ndufv1;Uqcrc2;Ndufc2;Sdhd;Ndufv2;Gnai2
prerank,Gastric acid secretion,-0.8550637838267832,-1.4930141763908718,0.0034762456546929316,0.038086264357696804,0.226,8/43,3.99%,Calm1;Calm2;Atp1b1;Actb;Calm3;Gnas;Kcnj2;Atp1a1
prerank,Neuroactive ligand-receptor interaction,0.6449604557108101,1.4889685756090134,0.039603960396039604,0.40161828544429024,0.659,12/75,3.08%,Grik4;Gria3;Gabrg3;Gria4;Grin1;Grin2a;Gabra2;Grm8;Gria1;Gabbr2;Chrm3;Trhr
prerank,C-type lectin receptor signaling pathway,-0.832750477200038,-1.4826608213231038,0.0,0.04676948847656529,0.285,5/55,2.53%,Calm1;Calm2;Calm3;Jun;Nfkb2
prerank,Alzheimer disease,-0.7902896408614053,-1.481584149380626,0.0,0.04397131395232634,0.292,48/126,9.35%,Calm1;Calm2;Gapdh;Cyc1;Calm3;Apoe;Atp5b;Ndufa3;Ndufa1;Uqcrq;Cox6c;Ndufs8;Ndufs5;Atp5o;Cox8a;Atp5h;Cox5b;Atp5j;Uqcrb;Ndufs2;Cox7a2l;Atp5d;Cox4i1;Psenen;Cox6b1;Cox6a1;Cox7c;Ndufa2;Uqcr10;Atp5e;Ndufs7;Ndufa4;Ndufb3;Uqcrc1;Ndufb11;Atp5g2;Ndufb10;Cox5a;Cox7a2;Cycs;Ppp3ca;Uqcrh;Bad;Ndufa13;Aph1a;Atp5g3;Atp5g1;Cox7b
prerank,Huntington disease,-0.781775366710824,-1.4790847861545835,0.0,0.04280540790056011,0.312,64/144,13.68%,Slc25a4;Cyc1;Atp5b;Ndufa3;Ndufa1;Uqcrq;Cox6c;Ndufs8;Ndufs5;Atp5o;Cox8a;Atp5h;Slc25a5;Cox5b;Clta;Atp5j;Uqcrb;Vdac1;Ndufs2;Bax;Cox7a2l;Atp5d;Cox4i1;Polr2f;Cox6b1;Cox6a1;Cox7c;Ndufa2;Uqcr10;Atp5e;Ap2m1;Ndufs7;Ndufa4;Ndufb3;Uqcrc1;Ndufb11;Atp5g2;Ndufb10;Bdnf;Cox5a;Polr2i;Sod1;Cox7a2;Cycs;Uqcrh;Ndufa13;Atp5g3;Atp5g1;Cox7b;Dnal4;Ndufb8;Polr2e;Atp5a1;Polr2c;Polr2g;Uqcr11;Ndufa8;Ndufa7;Vdac3;Ndufv1;Tbpl1;Uqcrc2;Ndufc2;Sdhd
prerank,Alcoholism,-0.8178516256708428,-1.4759317998473265,0.004429678848283499,0.044740043217227146,0.34,7/72,2.94%,Calm1;Calm2;H3f3a;H3f3b;Calm3;Gnas;Gnb2
prerank,Glioma,-0.8331245767451567,-1.4736200685973055,0.005681818181818182,0.04354302193331018,0.352,3/56,0.49%,Calm1;Calm2;Calm3
prerank,Neurotrophin signaling pathway,-0.7983134287161164,-1.473602634637996,0.001081081081081081,0.04064015380442283,0.352,14/94,7.74%,Calm1;Calm2;Calm3;Bex3;Rac1;Arhgdia;Jun;Bax;Maged1;Nfkbib;Bdnf;Cdc42;Bad;Ywhae
prerank,Phosphatidylinositol signaling system,-0.8003262474241272,-1.4639845366722843,0.003271537622682661,0.05071691325183095,0.421,3/74,0.49%,Calm1;Calm2;Calm3
prerank,Ferroptosis,-0.8618303996853602,-1.4596036392671257,0.00975609756097561,0.05396479439603687,0.459,9/31,10.29%,Fth1;Prnp;Acsl3;Ftl1;Map1lc3b;Trf;Gpx4;Pcbp1;Gclm
prerank,Legionellosis,-0.8782271088878212,-1.4582933510681593,0.009900990099009901,0.05246577232948029,0.467,10/25,8.17%,Eef1a1;Nfkb2;Hspa8;Arf1;Eef1g;Hspa2;Eef1a2;Il18;Cycs;Rab1b
prerank,Kaposi sarcoma-associated herpesvirus infection,-0.7895598741013746,-1.4505484301738283,0.0011001100110011,0.0611706197686071,0.527,18/97,10.10%,Calm1;Calm2;Ubb;Calm3;Gabarapl1;Rac1;Jun;Gnb2;Bax;Gabarapl2;Gabarap;Cycs;Ppp3ca;Gng2;Gng13;Angpt2;Cdk4;Gng10
prerank,Pentose phosphate pathway,-0.908053326594567,-1.4404933430205136,0.01740294511378849,0.0750510381322661,0.611,2/16,2.71%,Aldoa;Aldoc
prerank,Inflammatory mediator regulation of TRP channels,-0.8177902164402615,-1.4391678315569731,0.004602991944764097,0.07319034724965141,0.617,4/50,1.47%,Calm1;Calm2;Calm3;Gnas
prerank,Cellular senescence,-0.7868807062302098,-1.4374836739129002,0.0011013215859030838,0.0725435830391169,0.629,10/93,7.18%,Calm1;Calm2;Slc25a4;Calm3;Slc25a5;Vdac1;Ppp1ca;Rheb;Sqstm1;Ppp3ca
prerank,Tuberculosis,-0.7929215964061985,-1.4368771042926776,0.005488474204171241,0.07034541234072762,0.634,13/74,10.96%,Calm1;Calm2;Atp6v0c;Calm3;Bax;Il18;Cycs;Ppp3ca;Bad;Ifngr2;Atp6v0b;Nfyb;Lamp1
prerank,Viral myocarditis,-0.8812241866246383,-1.4284561788312646,0.0199501246882793,0.08111374960145049,0.701,3/19,1.87%,Actb;Rac1;Actg1
prerank,Non-alcoholic fatty liver disease (NAFLD),-0.7673113304529853,-1.4248964821829442,0.003243243243243243,0.08382531396184394,0.737,45/101,14.18%,Cyc1;Ndufa3;Rac1;Ndufa1;Uqcrq;Jun;Cox6c;Ndufs8;Ndufs5;Cox8a;Cox5b;Uqcrb;Ndufs2;Bax;Cox7a2l;Cox4i1;Cox6b1;Cox6a1;Cox7c;Ndufa2;Uqcr10;Ndufs7;Ndufa4;Ndufb3;Uqcrc1;Ndufb11;Ndufb10;Cox5a;Cdc42;Cox7a2;Cycs;Uqcrh;Ndufa13;Cox7b;Irs2;Ndufb8;Uqcr11;Ndufa8;Ndufa7;Ndufv1;Uqcrc2;Ndufc2;Sdhd;Xbp1;Ndufv2
prerank,Glutamatergic synapse,0.5923088777586613,1.4224140300716956,0.0379746835443038,0.47270472196792956,0.798,12/85,2.46%,Grik4;Gria3;Cacna1c;Shank2;Gria4;Cacna1a;Grin1;Adcy8;Grin2a;Dlgap1;Grm8;Gria1
prerank,Type II diabetes mellitus,0.6820489724644592,1.4200878395604204,0.08121827411167512,0.398606148303458,0.801,7/29,5.76%,Cacna1c;Gck;Cacna1a;Cacna1e;Cacna1b;Mapk10;Prkce
prerank,Mineral absorption,-0.867010645784626,-1.4048551131795337,0.02030456852791878,0.12026769349373174,0.868,8/21,7.53%,Fth1;Atp1b1;Mt1;Atp1a1;Ftl1;Trf;Atp1b2;Atp1a3
prerank,GnRH signaling pathway,-0.7819522761389034,-1.403606126597903,0.01557285873192436,0.11921852040441343,0.875,6/60,3.84%,Calm1;Calm2;Calm3;Gnas;Jun;Egr1
prerank,Antigen processing and presentation,-0.8566847427378756,-1.400037333319347,0.029262086513994912,0.12324102847190167,0.886,9/22,10.32%,Hsp90ab1;Hsp90aa1;Calr;Hspa8;Hspa2;Pdia3;Ctsb;Canx;Nfyb
prerank,Glycosphingolipid biosynthesis,0.6665591084166688,1.3985987558878301,0.09313725490196079,0.38569698912846306,0.84,7/29,10.78%,St6galnac3;St6galnac5;Sec1;Hexa;St3gal3;Gcnt2;Hexb
prerank,Rheumatoid arthritis,-0.8376118926497317,-1.396890327273069,0.024752475247524754,0.12626245636467373,0.901,10/27,10.19%,Atp6v0c;Atp6v1d;Jun;Atp6v1a;Atp6v1g2;Atp6v0e2;Il18;Atp6v1f;Tek;Atp6v0b
prerank,Phagosome,-0.7782264815723965,-1.395538824682945,0.01122334455667789,0.12501844035081874,0.906,22/69,10.96%,Actb;Tuba4a;Atp6v0c;Tubb2a;Atp6v1d;Rac1;Tuba1a;Actg1;Atp6v1a;Calr;Atp6v1g2;Atp6v0e2;Stx7;Tubb5;Tubb2b;Atp6v1f;Tubb4b;Tubb4a;Canx;Atp6v0b;Itgav;Lamp1
prerank,Thyroid hormone synthesis,-0.8167827121592465,-1.3948998548111973,0.020214030915576695,0.12224283175016237,0.91,6/39,7.53%,Ttr;Atp1b1;Gnas;Atp1a1;Atp1b2;Atp1a3
prerank,Fructose and mannose metabolism,-0.8539804190964213,-1.3767078528812817,0.04935064935064935,0.16408045703517227,0.958,3/18,2.73%,Aldoa;Aldoc;Pmm1
prerank,Oocyte meiosis,-0.7584303863607285,-1.3761813763792667,0.02188183807439825,0.16059220240302105,0.958,17/73,12.17%,Calm1;Calm2;Calm3;Ywhag;Ywhah;Ywhab;Anapc13;Ppp1ca;Ppp3ca;Smc1a;Ywhae;Ppp2r1a;Rbx1;Ppp2ca;Ywhaq;Anapc11;Ppp3r1
prerank,Collecting duct acid secretion,-0.862917582850214,-1.3734063537148875,0.041884816753926704,0.16377550891869141,0.963,6/16,6.78%,Atp6v0c;Atp6v1d;Atp6v1a;Atp6v1g2;Atp6v0e2;Atp6v1f
prerank,Influenza A,-0.7551774492000642,-1.3674824266859766,0.0221483942414175,0.1753141997839505,0.969,12/72,8.87%,Actb;Jun;Actg1;Hspa8;Vdac1;Hspa2;Il18;Nfkbib;Fdps;Pml;Cycs;Ifngr2
prerank,Human immunodeficiency virus 1 infection,-0.7394276373526434,-1.366678299338762,0.00857449088960343,0.1729704906798898,0.971,17/116,8.74%,Calm1;Calm2;Calm3;Rac1;Jun;Cfl1;Gnb2;Calr;Elob;Bax;Cycs;Ppp3ca;Bad;Gng2;Cfl2;Gng13;Pdia3
prerank,Glucagon signaling pathway,-0.7633346713221307,-1.3624139000002111,0.0223463687150838,0.17953152570092945,0.976,6/63,4.03%,Calm1;Calm2;Calm3;Gnas;Pgam1;Pkm
prerank,Bacterial invasion of epithelial cells,-0.7722909749874105,-1.3615465983923354,0.04176334106728538,0.17733168061036872,0.977,13/49,12.25%,Actb;Rac1;Actg1;Clta;Ctnna3;Arpc5l;Arpc5;Cdc42;Wasl;Arpc3;Ctnna1;Arpc2;Arpc1a
prerank,Cholesterol metabolism,-0.8310136567592232,-1.360930796248544,0.04928664072632944,0.1747065376031241,0.977,7/20,12.71%,Apoe;Nceh1;Vdac1;Ldlr;Lrpap1;Vapa;Vdac3
prerank,Mitophagy,-0.7663585749114912,-1.3535042698012913,0.04152249134948097,0.19000104693604647,0.981,13/56,12.78%,Ubb;Gabarapl1;Jun;Bnip3l;Gabarapl2;Cited2;Tomm7;Gabarap;Sqstm1;Pink1;Csnk2b;Kras;Hras
prerank,Proteasome,-0.7736166813613343,-1.3490509812630949,0.05041031652989449,0.19804153318328796,0.985,24/39,18.45%,Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Adrm1;Pomp;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4;Psmc6;Psmc1;Psmb6;Psmb10
prerank,Rap1 signaling pathway,-0.7278345588212728,-1.340653222106032,0.013993541442411194,0.21850031170141382,0.992,9/117,3.30%,Calm1;Calm2;Actb;Calm3;Pfn2;Rac1;Gnas;Actg1;Vegfc
prerank,NOD-like receptor signaling pathway,-0.7253957504641884,-1.3365750850238225,0.04065934065934066,0.22641043368053024,0.993,9/74,6.31%,Hsp90ab1;Gabarapl1;Jun;Hsp90aa1;Vdac1;Il18;Gabarapl2;Gabarap;Nfkbib
prerank,Renin secretion,-0.7730447305409833,-1.3309397205254012,0.04976303317535545,0.23836722103805005,0.994,5/38,3.02%,Calm1;Calm2;Calm3;Gnas;Kcnj2
prerank,Human cytomegalovirus infection,-0.7155594556477854,-1.3288574042161112,0.012806830309498399,0.23955483010290116,0.994,17/127,10.80%,Calm1;Calm2;Calm3;Rac1;Gnas;Gnb2;Calr;Bax;Rheb;Cycs;Ppp3ca;Gng2;Gng13;Pdia3;Cdk4;Gng10;Itgav
prerank,Thermogenesis,-0.6993471299556305,-1.3217999352506478,0.009424083769633508,0.2566586477434701,0.996,65/174,13.72%,Actb;Cyc1;Atp5b;Ndufa3;Gnas;Ndufa1;Uqcrq;Rps6;Actg1;Cox6c;Cox17;Acsl3;Ndufs8;Ndufs5;Atp5o;Cox8a;Atp5h;Coa3;Cox5b;Atp5j;Uqcrb;Ndufs2;Cox7a2l;Atp5d;Cox4i1;Cox6b1;Cox6a1;Cox7c;Ndufa2;Uqcr10;Atp5e;Ndufs7;Ndufa4;Ndufb3;Uqcrc1;Ndufb11;Atp5g2;Ndufb10;Cox5a;Rheb;Cox7a2;Atp5k;Uqcrh;Ndufa13;Atp5g3;Atp5l;Atp5g1;Cox7b;Cox20;Ndufb8;Atp5a1;Coa7;Uqcr11;Fgfr1;Adcy10;Kras;Ndufa8;Ndufa7;Hras;Ndufv1;Uqcrc2;Cox14;Ndufc2;Sdhd;Sirt6
prerank,Apoptosis,-0.7297465577687035,-1.3208236581442,0.03956043956043956,0.2543447086546072,0.997,10/77,9.41%,Actb;Tuba4a;Tuba1a;Jun;Actg1;Bax;Cycs;Bad;Ctso;Ctsb
prerank,Carbohydrate digestion and absorption,-0.8151934246172016,-1.320341730284201,0.08717948717948718,0.250607341876966,0.997,5/21,7.53%,Atp1b1;Atp1a1;Atp1b2;G6pc3;Atp1a3
prerank,HIF-1 signaling pathway,-0.7280732851459247,-1.3193139778120233,0.06333333333333334,0.24867450418400514,0.997,11/68,10.97%,Gapdh;Aldoa;Rps6;Elob;Trf;Ifngr2;Angpt2;Tek;Ldha;Pgk1;Rbx1
prerank,Salivary secretion,-0.7631565484166499,-1.3166609944101448,0.07168037602820211,0.25187568110328024,0.997,7/45,1.67%,Calm1;Calm2;Atp1b1;Calm3;Vamp2;Gnas;Cst3
prerank,Long-term depression,0.597471325763265,1.3165584077932733,0.1259259259259259,0.5134438767976848,0.923,9/47,4.81%,Prkg1;Gria3;Gucy1a2;Cacna1a;Gria1;Prkcg;Raf1;Pla2g4e;Nos1
prerank,Oxytocin signaling pathway,-0.7157885207367485,-1.3162655001906356,0.03282275711159737,0.24844576185452125,0.998,11/102,3.02%,Calm1;Calm2;Actb;Calm3;Kcnj3;Gnas;Myl6;Rgs2;Jun;Actg1;Kcnj2
prerank,Hippo signaling pathway,-0.7200403609678616,-1.3108720663380198,0.04560260586319218,0.2608106213492224,0.998,21/83,17.29%,Actb;Ywhag;Actg1;Ywhah;Ywhab;Ctnna3;Csnk1e;Ppp1ca;Ywhae;Ppp2r1a;Ppp2ca;Ctnna1;Ywhaq;Limd1;Fzd3;Ywhaz;Ccnd3;Bmpr1b;Smad7;Id2;Smad2
prerank,Aldosterone synthesis and secretion,-0.7320428672547293,-1.3095160223581055,0.07238307349665925,0.2602264596295265,1.0,5/63,1.47%,Calm1;Calm2;Atp1b1;Calm3;Gnas
prerank,Synaptic vesicle cycle,-0.7391032337190246,-1.3071260365861792,0.06425233644859812,0.2630691194580467,1.0,11/56,6.78%,Atp6v0c;Rab3a;Vamp2;Atp6v1d;Cplx2;Atp6v1a;Atp6v1g2;Atp6v0e2;Clta;Ap2m1;Atp6v1f
prerank,Fatty acid elongation,-0.8028926916216315,-1.3042701331897923,0.08376288659793814,0.2678434458558854,1.0,2/21,8.75%,Tecr;Hacd4
prerank,RNA transport,-0.7025374042823527,-1.3008968373929939,0.03329752953813104,0.2733573811370677,1.0,40/127,18.79%,Eef1a1;Eif1;Ran;Eif4a1;Eif1b;Eif1ax;Sumo2;Eif3c;Eef1a2;Sap18;Eif3f;Pabpc4;Eif3h;Pop5;Magoh;Rpp21;Eif4a2;Rbm8a;Eif3i;Ddx20;Magohb;Eif3a;Eif5b;Nup37;Eif2s2;Gemin7;Eif1a;Nup50;Sec13;Eif4ebp2;Nup107;Seh1l;Upf3a;Nup205;Pabpc1;Eif5;Fmr1;Eif3d;Pop4;Eif2b5
prerank,IL-17 signaling pathway,-0.7526019517539592,-1.3007017932381797,0.10134310134310134,0.2693330641689144,1.0,4/34,4.52%,Hsp90ab1;Jun;Hsp90aa1;Jund
prerank,Aldosterone-regulated sodium reabsorption,-0.7872182196041868,-1.2987354824754134,0.10899873257287707,0.271030081688908,1.0,6/24,11.76%,Atp1b1;Atp1a1;Atp1b2;Atp1a3;Atp1a2;Kras
prerank,Glutathione metabolism,-0.7834430040077475,-1.2965290580338513,0.10204081632653061,0.2732793448793656,1.0,8/26,10.29%,Gstm5;Gstm1;Srm;Gstp1;Hpgds;Gpx4;Odc1;Gclm
prerank,Lysosome,-0.6993380791709254,-1.2924592512190585,0.05837004405286344,0.28199936232077166,1.0,10/87,11.33%,Atp6v0c;Laptm4a;Clta;Psap;Fuca1;Ctso;Ctsb;Atp6v0b;Lamp1;Cd63
prerank,Spliceosome,-0.6975056865961629,-1.2922723625090489,0.033155080213903745,0.27803173214788757,1.0,35/120,16.11%,Ddx5;Zmat2;Hspa8;Snrpg;Sf3b4;Snw1;Hspa2;Snrpf;Snrpd2;Snrnp27;Wbp11;Magoh;Snu13;Bud31;Lsm2;Rbm8a;Sf3b2;Magohb;Pcbp1;Rbm22;Lsm4;Hnrnpa1;Txnl4a;Lsm7;Puf60;Ccdc12;Snrnp200;U2af1l4;Lsm8;Ctnnbl1;Syf2;U2af1;Snrpd1;Phf5a;Rbmxl1
prerank,Insulin signaling pathway,-0.698892424686515,-1.291879608115639,0.054371002132196165,0.27474011961781614,1.0,4/94,1.65%,Calm1;Calm2;Calm3;Rps6
prerank,Biosynthesis of unsaturated fatty acids,-0.7768986510198974,-1.2916584760017586,0.11794871794871795,0.271013672033007,1.0,3/21,8.75%,Tecr;Scp2;Hacd4
prerank,Long-term potentiation,-0.7318648267854565,-1.2911629934116293,0.08053691275167785,0.268652860990687,1.0,4/54,1.34%,Calm1;Calm2;Calm3;Ppp1r1a
prerank,Vasopressin-regulated water reabsorption,-0.7505527800065951,-1.2774874113807055,0.09806295399515738,0.3062002407952907,1.0,7/34,7.26%,Dynll2;Vamp2;Dynll1;Gnas;Arhgdia;Dctn6;Aqp4
prerank,Base excision repair,-0.8125968730308698,-1.273236707951572,0.13324175824175824,0.3150520418064925,1.0,3/15,7.45%,Hmgb1;Pcna;Mpg
prerank,Tight junction,-0.703916414068744,-1.2706590136020726,0.05945945945945946,0.3183893038081269,1.0,13/92,9.44%,Actb;Tuba4a;Rac1;Myl6;Tuba1a;Jun;Actg1;Cdc42;Pcna;Wasl;Myl12b;Ppp2r1a;Cdk4
prerank,Glycolysis / Gluconeogenesis,-0.7322042360084098,-1.2656823046398435,0.1278928136419001,0.33018165460124194,1.0,11/34,12.82%,Gapdh;Aldoa;Aldoc;Pgam1;Pkm;G6pc3;Tpi1;Ldha;Pgk1;Dlat;Eno2
prerank,Cysteine and methionine metabolism,-0.7634935484858371,-1.2649041507350807,0.13274336283185842,0.32803237473855046,1.0,8/26,14.85%,Mdh2;Srm;Mdh1;Mat2b;Ldha;Gclm;Got2;Ldhb
prerank,Amphetamine addiction,-0.7252938588765793,-1.264430386331939,0.12958715596330275,0.3247738380199584,1.0,5/45,1.75%,Calm1;Calm2;Calm3;Gnas;Jun
prerank,Viral carcinogenesis,-0.6813314211704105,-1.26009110533764,0.07518796992481203,0.33414820525871547,1.0,25/107,14.58%,Rac1;Ywhag;Jun;Ywhah;Nfkb2;Ywhab;Pkm;Snw1;Bax;Ube3a;Cdc42;Bad;Ywhae;Cdk4;Kras;Ywhaq;Ranbp1;Lyn;Vdac3;Hras;Dnaja3;Tbpl1;Cdkn1b;Ywhaz;Ccnd3
prerank,Bile secretion,-0.7491735297667037,-1.2596561865371143,0.13017031630170317,0.330770322852869,1.0,8/30,9.72%,Atp1b1;Gnas;Atp1a1;Nceh1;Atp1b2;Aqp4;Atp1a3;Ldlr
prerank,Apelin signaling pathway,-0.6858983496680726,-1.2594340940128388,0.09251101321585903,0.32701953539637973,1.0,9/89,6.28%,Calm1;Calm2;Calm3;Gabarapl1;Rps6;Gnb2;Egr1;Gabarapl2;Gabarap
prerank,Prion diseases,-0.7680448208415717,-1.2592220768784772,0.14923469387755103,0.3233161017606403,1.0,5/20,10.38%,Prnp;Egr1;Bax;Sod1;Ncam2
prerank,p53 signaling pathway,-0.7385737084153791,-1.2569916981870113,0.12323943661971831,0.3256408914184556,1.0,9/36,14.58%,Rprm;Sesn1;Bax;Cycs;Ppm1d;Cop1;Cdk4;Siva1;Ccnd3
prerank,Leukocyte transendothelial migration,-0.7099798023929925,-1.2559829684542456,0.14168618266978922,0.3248144130533389,1.0,6/50,8.60%,Actb;Rac1;Actg1;Ctnna3;Cdc42;Myl12b
prerank,Vascular smooth muscle contraction,-0.7015199768075479,-1.2546742373735893,0.09966405375139978,0.3246064147761612,1.0,6/63,3.49%,Calm1;Calm2;Calm3;Gnas;Myl6;Ramp2
prerank,Thyroid hormone signaling pathway,-0.6901521955970841,-1.2545555061244245,0.07903402854006586,0.3208163465519381,1.0,13/88,12.78%,Atp1b1;Actb;Actg1;Atp1a1;Rheb;Atp1b2;Bad;Atp1a3;Med4;Itgav;Atp1a2;Kras;Hras
prerank,Adrenergic signaling in cardiomyocytes,-0.680366915541541,-1.2418753049861062,0.10979547900968784,0.3563751026078647,1.0,6/91,1.47%,Calm1;Calm2;Atp1b1;Calm3;Ppp1r1a;Gnas
prerank,Pathways in cancer,-0.6495025774903764,-1.2413070763463319,0.04081632653061224,0.3536193055006972,1.0,35/261,11.76%,Calm1;Calm2;Hsp90ab1;Calm3;Rac1;Gnas;Jun;Gstm5;Rasgrp1;Nfkb2;Gstm1;Gnb2;Hsp90aa1;Vegfc;Elob;Bax;Ctnna3;Gstp1;Fgfr2;Pml;Cdc42;Cycs;Bad;Pdgfa;Gng2;Gng13;Ifngr2;Cdk4;Vegfb;Gng10;Itgav;Rbx1;Ctnna1;Fgfr1;Kras
prerank,Endocrine and other factor-regulated calcium reabsorption,-0.7346585420692878,-1.2403001003138008,0.14945321992709598,0.3524120683878366,1.0,10/33,11.73%,Atp1b1;Gnas;Clta;Atp1a1;Ap2m1;Atp1b2;Atp1a3;Calb1;Rab11a;Atp1a2
prerank,Protein export,-0.7533187530403885,-1.23950043145686,0.16084788029925187,0.35055179449132895,1.0,14/26,19.54%,Srp14;Sec62;Spcs2;Arxes1;Srp9;Arxes2;Sec61g;Srp19;Immp2l;Srprb;Spcs1;Srpr;Oxa1l;Srp72
prerank,Olfactory transduction,-0.7337590981808001,-1.2394881713386683,0.17125,0.3464005209223518,1.0,4/31,1.63%,Calm1;Calm2;Calm3;Rgs2
prerank,Measles,-0.690752562760125,-1.2343820080203016,0.14777777777777779,0.3580997158996274,1.0,11/65,10.15%,Rack1;Jun;Hspa8;Bax;Hspa2;Eif3h;Nfkbib;Cycs;Bad;Cdk4;Csnk2b
prerank,Drug metabolism,-0.7276714398546305,-1.2300636854846658,0.1905972045743329,0.36696060189305074,1.0,15/28,18.56%,Gstm5;Gstm1;Nme2;Nme7;Gstp1;Hpgds;Uckl1;Itpa;Tk2;Dut;Impdh2;Adh5;Gsto1;Hprt;Gstm7
prerank,ABC transporters,0.610356402162732,1.228552141433334,0.20187793427230047,0.6709256579616559,0.975,5/24,7.45%,Abcb1b;Abcb8;Abcc5;Abca5;Abca3
prerank,Adherens junction,-0.6831802242524834,-1.2282276155319383,0.15903890160183065,0.36806220880707835,1.0,10/55,11.74%,Actb;Rac1;Acp1;Actg1;Ctnna3;Cdc42;Wasl;Csnk2b;Ctnna1;Fgfr1
prerank,Th17 cell differentiation,-0.7005091501272144,-1.225771291763707,0.1630057803468208,0.3701722997459949,1.0,6/42,8.87%,Hsp90ab1;Jun;Hsp90aa1;Nfkbib;Ppp3ca;Ifngr2
prerank,Salmonella infection,-0.7009850453917719,-1.2246734865789455,0.16022727272727272,0.3693272397617658,1.0,15/43,12.25%,Actb;Pfn2;Rac1;Jun;Actg1;Il18;Arpc5l;Arpc5;Cdc42;Wasl;Ifngr2;Arpc3;Pfn1;Arpc2;Arpc1a
prerank,Glyoxylate and dicarboxylate metabolism,-0.7600042977768859,-1.219434163812586,0.1916243654822335,0.3808751198322036,1.0,4/19,6.98%,Mdh2;Mcee;Glul;Mdh1
prerank,Protein processing in endoplasmic reticulum,-0.6497038027001019,-1.2191429572009291,0.11181434599156118,0.3774537563589468,1.0,27/134,14.03%,Hsp90ab1;Hsp90aa1;Calr;Hspa8;Sec62;Dnaja1;Bax;Hspa2;Ube2j1;Dnaja2;Pdia6;Pdia3;Bag1;Ddost;Dad1;Rnf5;Canx;Ubqln2;Rbx1;Ssr2;Lman2;Sec61g;P4hb;Cryab;Dnajb2;Ssr3;Xbp1
prerank,cGMP-PKG signaling pathway,-0.6558909778216724,-1.2093053877186846,0.1389496717724289,0.4045602484240135,1.0,14/95,7.53%,Calm1;Calm2;Atp1b1;Slc25a4;Calm3;Rgs2;Slc25a5;Atp1a1;Vdac1;Ppp1ca;Atp1b2;Ppp3ca;Bad;Atp1a3
prerank,Dopaminergic synapse,-0.6617123116444761,-1.205830601010018,0.15075921908893708,0.41052565914038275,1.0,7/96,2.94%,Calm1;Calm2;Caly;Calm3;Kcnj3;Gnas;Gnb2
prerank,Prolactin signaling pathway,0.5507027908246283,1.2041505994461892,0.22695035460992907,0.6654814989811889,0.985,9/41,10.67%,Gck;Mapk14;Raf1;Mapk10;Akt2;Jak2;Sos1;Ccnd2;Pik3r3
prerank,PI3K-Akt signaling pathway,-0.6404778761033818,-1.2027786957062696,0.11328527291452112,0.4153526877319819,1.0,35/175,14.58%,Hsp90ab1;Rac1;Rps6;Ywhag;Ywhah;Ywhab;Gnb2;Hsp90aa1;Vegfc;Fgfr2;Bdnf;Rheb;G6pc3;Cdc37;Bad;Ywhae;Pdgfa;Gng2;Gng13;Angpt2;Ppp2r1a;Tek;Cdk4;Vegfb;Gng10;Itgav;Ppp2ca;Fgfr1;Kras;Ywhaq;Hras;Gng3;Cdkn1b;Ywhaz;Ccnd3
prerank,SNARE interactions in vesicular transport,-0.7216822935287103,-1.198222459368088,0.2147165259348613,0.425413957399018,1.0,10/28,19.42%,Vamp2;Stx7;Bet1l;Stx16;Vamp3;Vti1b;Snap29;Stx4a;Gosr1;Use1
prerank,Citrate cycle (TCA cycle),-0.7287952262236375,-1.19662783401152,0.20993788819875778,0.42599577268263333,1.0,10/27,18.09%,Mdh2;Idh3b;Mdh1;Dlat;Sdhd;Acly;Idh3a;Suclg1;Sdhb;Idh2
prerank,Prostate cancer,-0.6616971893711106,-1.19240032291435,0.2061503416856492,0.4343104141583824,1.0,9/66,12.78%,Hsp90ab1;Hsp90aa1;Gstp1;Fgfr2;Bad;Pdgfa;Fgfr1;Kras;Hras
prerank,Autophagy,-0.6448246535714894,-1.187301775255681,0.1603875134553283,0.44629647354752217,1.0,16/113,12.78%,Hmgb1;Gabarapl1;Rraga;Gabarapl2;Gabarap;Rheb;Sh3glb1;Bad;Ctsb;Irs2;Atg12;Lamp1;Ppp2ca;Kras;Rragd;Hras
prerank,Cardiac muscle contraction,-0.6802407722296667,-1.1840985184230082,0.21703617269544925,0.45235795151326447,1.0,20/46,7.53%,Atp1b1;Cyc1;Uqcrq;Cox6c;Cox8a;Cox5b;Atp1a1;Uqcrb;Cox7a2l;Cox4i1;Cox6b1;Cox6a1;Cox7c;Uqcr10;Uqcrc1;Cox5a;Atp1b2;Cox7a2;Uqcrh;Atp1a3
prerank,cAMP signaling pathway,-0.6330691125383661,-1.1782433633475378,0.18036286019210246,0.4659384548694856,1.0,14/115,7.53%,Calm1;Calm2;Atp1b1;Calm3;Rac1;Gnas;Jun;Npy1r;Atp1a1;Ppp1ca;Bdnf;Atp1b2;Bad;Atp1a3
prerank,"Glycine, serine and threonine metabolism",-0.7351168951181897,-1.177296227372732,0.2967479674796748,0.46412721224724823,1.0,2/16,3.24%,Pgam1;Phgdh
prerank,Regulation of actin cytoskeleton,-0.632112652904598,-1.1768773833767714,0.16344086021505377,0.46093691729728226,1.0,25/129,12.78%,Actb;Pfn2;Rac1;Tmsb4x;Actg1;Cfl1;Brk1;Fgfr2;Arpc5l;Arpc5;Ppp1ca;Cdc42;Wasl;Pdgfa;Cfl2;Myl12b;Arpc3;Itgav;Pfn1;Fgfr1;Kras;Arpc2;Arpc1a;Pip4k2a;Hras
prerank,Ras signaling pathway,-0.6276478262176202,-1.17630999128264,0.17640918580375783,0.45824026846351495,1.0,20/135,10.10%,Calm1;Calm2;Calm3;Rac1;Rasgrp1;Gnb2;Vegfc;Ets2;Fgfr2;Bdnf;Cdc42;Bad;Pdgfa;Gng2;Rasal2;Gng13;Angpt2;Tek;Vegfb;Gng10
prerank,Glycerolipid metabolism,0.5358460414126867,1.1755433366827968,0.23353293413173654,0.6828423621383489,0.991,8/35,12.81%,Dgkg;Plpp4;Dgkq;Dgkh;Lpin1;Mboat2;Dgkb;Dgat1
prerank,Epstein-Barr virus infection,-0.6399466083192569,-1.1658273511937027,0.2084233261339093,0.48733255895795397,1.0,23/96,14.58%,Rac1;Jun;Psmc3;Nfkb2;Calr;Psmc2;Snw1;Bax;Nfkbib;Sem1;Cycs;Adrm1;Pdia3;Psmd2;Psmc5;Cdk4;Psmd4;Psmd7;Lyn;Psmd6;Psmc4;Cdkn1b;Ccnd3
prerank,Pyrimidine metabolism,-0.6817602453040127,-1.1545820105512445,0.2858926342072409,0.5188826446922356,1.0,6/28,13.99%,Dtymk;Nme2;Nme7;Uckl1;Tk2;Dut
prerank,Cell cycle,-0.6389430586906129,-1.1482046792389091,0.23893805309734514,0.5350509429562619,1.0,16/73,14.88%,Ywhag;Ywhah;Ywhab;Anapc13;Pcna;Smc1a;Ywhae;Cdk4;Rbx1;Ywhaq;Anapc11;Rad21;Cdkn1b;Ywhaz;Ccnd3;Stag1
prerank,Human T-cell leukemia virus 1 infection,-0.6140865881305192,-1.1467445009310988,0.21360255047821466,0.5343400859511149,1.0,23/123,13.15%,Slc25a4;Ran;Jun;Nfkb2;Calr;Slc25a5;Egr1;Vdac1;Bax;Ets2;Fdps;Gps2;Ppp3ca;Cdk4;Canx;Nfyb;Kras;Ranbp1;Anapc11;Ppp3r1;Vdac3;Hras;Tbpl1
prerank,Amyotrophic lateral sclerosis (ALS),-0.6706912439574911,-1.144960119460513,0.2829736211031175,0.5346792228425612,1.0,8/36,7.46%,Nefl;Rac1;Nefm;Bax;Sod1;Cycs;Ppp3ca;Bad
prerank,beta-Alanine metabolism,-0.7182379640034364,-1.1400312234200027,0.2963917525773196,0.5449037744159498,1.0,2/18,7.11%,Srm;Aldh6a1
prerank,Hepatocellular carcinoma,-0.6123399197178263,-1.1325338014597157,0.2692725298588491,0.5631738804911588,1.0,12/101,14.02%,Actb;Gstm5;Actg1;Gstm1;Bax;Gstp1;Bad;Cdk4;Kras;Hras;Brd7;Fzd3
prerank,Transcriptional misregulation in cancer,-0.6189984322347207,-1.1218486542704387,0.292896174863388,0.592031951449855,1.0,8/83,7.77%,H3f3a;H3f3b;Ddx5;Bax;Tspan7;Eya1;Pml;Pdgfa
prerank,Proteoglycans in cancer,-0.6045747181297492,-1.1193804115870958,0.2829581993569132,0.5943419923347304,1.0,8/109,6.70%,Actb;Ddx5;Rac1;Rps6;Actg1;Timp3;Ppp1ca;Cdc42
prerank,Endocytosis,-0.5916244408238915,-1.1176338803890826,0.23834196891191708,0.5947548504071154,1.0,35/185,15.08%,Ubb;Hspa8;Arf1;Clta;Vps29;Hspa2;Fgfr2;Ap2m1;Arpc5l;Arpc5;Capza2;Pml;Cdc42;Cyth2;Vps28;Sh3glb1;Wasl;Ldlr;Arpc3;Chmp4b;Rab31;Rab11a;Rab22a;Arpc2;Arpc1a;Hras;Arf3;Chmp2a;Arfgap2;Cyth4;Epn1;Ehd3;Arf5;Snx3;Tsg101
prerank,Starch and sucrose metabolism,0.5945866520394743,1.1136096844750827,0.35655737704918034,0.7936981366092785,0.998,2/16,6.48%,Gck;Pgm2l1
prerank,RNA degradation,-0.6185784758922336,-1.1131171988920818,0.3211428571428571,0.603411655464044,1.0,22/63,23.22%,Tob1;Pabpc4;Btg2;Lsm2;C1d;Exosc3;Lsm4;Exosc4;Lsm7;Eno2;Lsm8;Pfkl;Cnot8;Pabpc1;Lsm1;Zcchc7;Hspd1;Eno1;Btg1;Mphosph6;Exosc9;Hspa9
prerank,Hepatitis C,-0.6128286303213883,-1.1118478243915317,0.3010869565217391,0.6021334953663061,1.0,18/81,15.41%,Ywhag;Ywhah;Ywhab;Bax;Cd81;Cycs;Bad;Ywhae;Ppp2r1a;Cdk4;Ldlr;Ppp2ca;Kras;Ywhaq;Hras;Psme3;Ywhaz;Cldn10
prerank,DNA replication,-0.7079826718357852,-1.109569466461433,0.3772290809327846,0.6038756082729465,1.0,6/15,23.38%,Pcna;Rpa3;Rnaseh1;Rnaseh2c;Rnaseh2a;Mcm6
prerank,Protein digestion and absorption,-0.6952660114889418,-1.1095157326849163,0.3618421052631579,0.5989282361441378,1.0,6/19,11.73%,Atp1b1;Atp1a1;Atp1b2;Atp1a3;Slc38a2;Atp1a2
prerank,Purine metabolism,0.4866574094496155,1.1066678138928523,0.29292929292929293,0.7511806623521475,0.999,10/81,5.99%,Pde2a;Pde9a;Gucy1a2;Pde1a;Adcy8;Ak5;Pde7b;Pfas;Adcy2;Pde10a
prerank,ECM-receptor interaction,0.5226677805502263,1.1027952673306587,0.3,0.7080673807484782,1.0,5/25,8.81%,Thbs3;Lamb1;Tnr;Sv2b;Lamc1
prerank,Peroxisome,-0.6199971114558771,-1.1002227512245362,0.3294663573085847,0.6215774007262417,1.0,10/57,19.51%,Acsl3;Prdx5;Sod1;Scp2;Mpv17;Prdx1;Nudt19;Idh2;Pex11b;Pex19
prerank,Calcium signaling pathway,-0.6036187296851325,-1.0998055061405625,0.31487513572204123,0.6175716842676404,1.0,7/91,4.38%,Calm1;Calm2;Slc25a4;Calm3;Gnas;Slc25a5;Vdac1
prerank,Leishmaniasis,-0.6692248052794989,-1.096982979160966,0.3707865168539326,0.6209646423943596,1.0,4/24,8.87%,Jun;Nfkbib;Marcksl1;Ifngr2
prerank,RNA polymerase,-0.6618785524731472,-1.0913581897796205,0.37435897435897436,0.6325540004853976,1.0,7/24,12.68%,Polr2f;Polr2i;Polr2e;Polr2c;Polr2g;Polr3h;Polr3d
prerank,Human papillomavirus infection,-0.5664257810772687,-1.061664932143934,0.3861997940267765,0.7148889919394184,1.0,27/173,14.65%,Atp6v0c;Atp6v1d;Gnas;Atp6v1a;Atp6v1g2;Atp6v0e2;Pkm;Bax;Ube3a;Rheb;Cdc42;Atp6v1f;Bad;Ppp2r1a;Cdk4;Atp6v0b;Itgav;Ppp2ca;Kras;Hras;Jag1;Tbpl1;Fzd3;Atp6v1e1;Cdkn1b;Ccnd3;Hey1
prerank,Galactose metabolism,0.5664000468191669,1.0576216997861316,0.39591836734693875,0.7775330006201459,1.0,1/17,0.43%,Gck
prerank,AGE-RAGE signaling pathway in diabetic complications,-0.6017290474366179,-1.0538232799607363,0.42462600690448793,0.7318094666890615,1.0,14/52,17.95%,Rac1;Jun;Vegfc;Egr1;Bax;Cdc42;Cdk4;Vegfb;Kras;Hras;Cdkn1b;Pik3r1;Smad2;Mapk3
prerank,B cell receptor signaling pathway,-0.6087283692284339,-1.050930872292937,0.4511904761904762,0.73398457707672,1.0,10/39,14.45%,Rac1;Jun;Cd81;Nfkbib;Ppp3ca;Kras;Ppp3r1;Lyn;Hras;Ppp3cb
prerank,Circadian entrainment,-0.5812787098021184,-1.0497207892061955,0.4236343366778149,0.7316839536480578,1.0,6/74,2.94%,Calm1;Calm2;Calm3;Kcnj3;Gnas;Gnb2
prerank,Focal adhesion,-0.5619138195475644,-1.0463363245151232,0.42394822006472493,0.7352083640672514,1.0,12/111,10.80%,Actb;Rac1;Jun;Actg1;Vegfc;Ppp1ca;Cdc42;Bad;Pdgfa;Myl12b;Vegfb;Itgav
prerank,Renal cell carcinoma,-0.5805381577919668,-1.0270386465929477,0.47613636363636364,0.7835126607879621,1.0,8/56,12.78%,Rac1;Jun;Elob;Cdc42;Bad;Rbx1;Kras;Hras
prerank,Cocaine addiction,-0.596207951484016,-1.026648576734032,0.48246674727932287,0.7783740933314633,1.0,4/32,6.37%,Gnas;Jun;Grm3;Bdnf
prerank,Ribosome biogenesis in eukaryotes,-0.569398720521341,-1.020879715591573,0.4869466515323496,0.788462184788971,1.0,13/65,14.77%,Ran;Pop5;Emg1;Nop10;Snu13;Eif6;Fbll1;Gar1;Csnk2b;Fcf1;Dkc1;Nhp2;Imp3
prerank,Osteoclast differentiation,-0.5753446009037246,-1.018728135708638,0.4816933638443936,0.7884546194725014,1.0,12/62,15.10%,Rac1;Jun;Nfkb2;Junb;Jund;Sqstm1;Ppp3ca;Ifngr2;Fosl2;Ppp3r1;Ppp3cb;Csf1r
prerank,Wnt signaling pathway,-0.5605286466380716,-1.018127516927494,0.48903508771929827,0.7840500391502833,1.0,14/84,14.58%,Rac1;Jun;Cacybp;Csnk1e;Ppp3ca;Bambi;Ruvbl1;Csnk2b;Rbx1;Ppp3r1;Fzd3;Tbl1xr1;Ppp3cb;Ccnd3
prerank,Toll-like receptor signaling pathway,-0.5854573726949683,-1.0173742099037608,0.4859154929577465,0.7799720771040426,1.0,2/40,1.75%,Rac1;Jun
prerank,Thyroid cancer,-0.6192750507951994,-1.006001812679,0.5217391304347826,0.8047250127297907,1.0,5/22,17.95%,Bax;Kras;Hras;Ddb2;Mapk3
prerank,Fatty acid degradation,-0.6133551558788274,-1.0012917049773271,0.519159456118665,0.8112752507574632,1.0,1/24,2.32%,Acsl3
prerank,Terpenoid backbone biosynthesis,-0.626299668166563,-0.9976989643512091,0.525974025974026,0.8145357765534483,1.0,4/17,18.12%,Fdps;Hmgcs1;Hmgcr;Pcyox1
prerank,mTOR signaling pathway,-0.5404550926146566,-0.9969605249249515,0.5155412647374062,0.8103380175790079,1.0,21/108,17.95%,Atp6v1d;Rps6;Atp6v1a;Lamtor2;Atp6v1g2;Rraga;Rheb;Atp6v1f;Lamtor3;Kras;Rragd;Hras;Fzd3;Atp6v1e1;Tbc1d7;Sec13;Pik3r1;Akt1s1;Seh1l;Tti1;Mapk3
prerank,Pancreatic secretion,-0.5713154977000559,-0.9899056726844541,0.5442739079102715,0.8220886850007375,1.0,6/46,7.53%,Atp1b1;Rac1;Gnas;Atp1a1;Atp1b2;Atp1a3
prerank,Progesterone-mediated oocyte maturation,-0.5538346682765505,-0.986045243016308,0.5312855517633674,0.8259721004395846,1.0,3/58,5.16%,Hsp90ab1;Hsp90aa1;Anapc13
prerank,Insulin resistance,0.4362375212307716,0.9825081148051211,0.4344262295081967,0.9515843250745651,1.0,10/58,10.67%,Rps6ka2;Prkag2;Ppargc1b;Ptprf;Mapk10;Prkce;Rps6ka6;Akt2;Ikbkb;Pik3r3
prerank,Natural killer cell mediated cytotoxicity,-0.5736549205123048,-0.9820144283349648,0.5491124260355029,0.8304364999148589,1.0,9/38,17.95%,Rac1;Ppp3ca;Ifngr2;Kras;Ppp3r1;Hras;Ppp3cb;Pik3r1;Mapk3
prerank,Fc gamma R-mediated phagocytosis,-0.5516896389737111,-0.9781669704759214,0.5352601156069364,0.8341752244330635,1.0,13/56,12.28%,Rac1;Cfl1;Arpc5l;Arpc5;Cdc42;Marcksl1;Wasl;Cfl2;Arpc3;Marcks;Arpc2;Arpc1a;Lyn
prerank,Glycerophospholipid metabolism,0.42151522153559196,0.9749526683158075,0.44537815126050423,0.9192924430794672,1.0,17/59,18.50%,Dgkg;Plpp4;Pla2g4e;Dgkq;Pcyt2;Dgkh;Chka;Lpin1;Mboat2;Dgkb;Pnpla6;Pgs1;Etnk1;Cds1;Dgka;Dgki;Pla2g3
prerank,Chagas disease (American trypanosomiasis),-0.5498402264751902,-0.9741040530998892,0.5455580865603644,0.837981888006396,1.0,13/52,17.95%,Gnas;Jun;Calr;Ifngr2;Ppp2r1a;Ppp2ca;Gnai2;C1qb;Gnai1;Pik3r1;Gna11;Smad2;Mapk3
prerank,Colorectal cancer,-0.5372346709964563,-0.9651081571343242,0.560315670800451,0.8534574050424449,1.0,12/62,17.95%,Rac1;Jun;Bax;Cycs;Bad;Kras;Hras;Rala;Pik3r1;Ddb2;Smad2;Mapk3
prerank,"Valine, leucine and isoleucine degradation",-0.5662038706052844,-0.9632015281869175,0.5719298245614035,0.8520497727605874,1.0,4/37,8.38%,Mcee;Aldh6a1;Hmgcs1;Acad8
prerank,Nucleotide excision repair,-0.56628324862464,-0.9586027108193489,0.5733830845771144,0.8567417772840901,1.0,6/32,18.32%,Cetn2;Pcna;Rpa3;Rbx1;Ddb2;Gtf2h5
prerank,"Parathyroid hormone synthesis, secretion and action",-0.5351283801852125,-0.9585281889660016,0.5695067264573991,0.8509864992838005,1.0,12/63,17.95%,Naca;Gnas;Egr1;Jund;Fgfr1;Mef2c;Gnai2;Nr4a2;Gnai1;Gna11;Arhgef1;Mapk3
prerank,mRNA surveillance pathway,-0.5316079784336902,-0.9561135919374953,0.5923423423423423,0.8508724931994284,1.0,10/75,11.40%,Sap18;Wdr82;Pabpc4;Cpsf2;Ppp1ca;Magoh;Rbm8a;Magohb;Ppp2r1a;Ppp2ca
prerank,Propanoate metabolism,-0.5757423367069775,-0.9521977008223497,0.5867665418227216,0.8540250421104927,1.0,7/24,20.78%,Mcee;Aldh6a1;Ldha;Ldhb;Suclg1;Dbt;Echdc1
prerank,Arginine and proline metabolism,-0.5682549175719955,-0.9467185781548734,0.6032540675844806,0.8609417393686705,1.0,5/28,14.54%,Srm;Ckb;Odc1;Got2;Ckmt1
prerank,Platelet activation,-0.5257607069226486,-0.943439462023056,0.6026936026936027,0.8623225723141491,1.0,6/65,6.21%,Actb;Gnas;Actg1;Rasgrp1;P2ry12;Ppp1ca
prerank,Gap junction,-0.524272412198215,-0.9417282128364072,0.6111111111111112,0.8602240411201219,1.0,13/63,12.78%,Tuba4a;Tubb2a;Gnas;Tuba1a;Tubb5;Tubb2b;Pdgfa;Gja1;Tubb4b;Tubb4a;Adrb1;Kras;Hras
prerank,Insulin secretion,-0.521569669695942,-0.9310224470019477,0.6194285714285714,0.8778672960973078,1.0,7/55,7.53%,Atp1b1;Rab3a;Vamp2;Gnas;Atp1a1;Atp1b2;Atp1a3
prerank,Glycosaminoglycan biosynthesis,-0.531347173566552,-0.9249669363846463,0.6275449101796408,0.8848201112065427,1.0,1/41,1.00%,Ndst4
prerank,T cell receptor signaling pathway,-0.5181273924973369,-0.9185031858100384,0.6396807297605474,0.8927925591399897,1.0,11/54,14.45%,Jun;Rasgrp1;Nck1;Nfkbib;Cdc42;Ppp3ca;Cdk4;Kras;Ppp3r1;Hras;Ppp3cb
prerank,Relaxin signaling pathway,-0.5037753830175533,-0.9162658394073634,0.6501103752759382,0.8915425576237054,1.0,16/77,17.95%,Gnas;Jun;Gnb2;Vegfc;Gng2;Gng13;Vegfb;Gng10;Kras;Hras;Gng3;Gnai2;Gnai1;Pik3r1;Smad2;Mapk3
prerank,Cytosolic DNA-sensing pathway,-0.5382541011325616,-0.908506663690154,0.6281094527363185,0.9013924682036439,1.0,6/28,12.68%,Polr2f;Il18;Nfkbib;Polr2e;Polr3h;Polr3d
prerank,Sphingolipid metabolism,0.4441556155280578,0.8979286139696335,0.5756097560975609,1.0,1.0,8/28,22.05%,Cers4;Sgms1;Gal3st1;Cers6;Sgpl1;Cers5;Sptlc1;Cerk
prerank,Morphine addiction,0.39869516637947594,0.8977094163181707,0.6017699115044248,1.0,1.0,13/67,5.99%,Pde2a;Pde1a;Gabrg3;Cacna1a;Adcy8;Gabra2;Gabbr2;Cacna1b;Prkcg;Pde7b;Adcy2;Kcnj6;Pde10a
prerank,FoxO signaling pathway,-0.48043618855954234,-0.8890932566661816,0.7080213903743315,0.9348288451451103,1.0,11/87,12.78%,Gabarapl1;Csnk1e;Plk2;Gabarapl2;Gabarap;G6pc3;Irs2;Atg12;Fbxo32;Kras;Hras
prerank,VEGF signaling pathway,-0.514790018309982,-0.8851106064436413,0.6919431279620853,0.9364531783477518,1.0,10/37,17.95%,Rac1;Cdc42;Ppp3ca;Bad;Kras;Ppp3r1;Hras;Ppp3cb;Pik3r1;Mapk3
prerank,Pancreatic cancer,-0.49705710949634063,-0.8784021047124346,0.6903153153153153,0.9429071583236764,1.0,11/56,17.95%,Rac1;Bax;Cdc42;Bad;Cdk4;Kras;Rala;Pik3r1;Ddb2;Smad2;Mapk3
prerank,Chemokine signaling pathway,-0.4746721452832464,-0.8713555557409617,0.7426067907995619,0.9496526166202724,1.0,15/96,14.24%,Rac1;Gnb2;Nfkbib;Cdc42;Bad;Wasl;Gng2;Ccl27a;Gng13;Gng10;Kras;Lyn;Hras;Gng3;Gnai2
prerank,Other types of O-glycan biosynthesis,0.4508269145481235,0.8704282980189125,0.6494464944649446,1.0,1.0,2/20,7.53%,Colgalt2;St3gal3
prerank,Endometrial cancer,-0.4920658125553189,-0.8698557622656579,0.7136150234741784,0.9463763128115612,1.0,10/46,17.95%,Bax;Ctnna3;Bad;Ctnna1;Kras;Hras;Ilk;Pik3r1;Ddb2;Mapk3
prerank,Regulation of lipolysis in adipocytes,0.40334448967982744,0.8670329008002089,0.6358381502890174,1.0,1.0,2/35,1.29%,Prkg1;Adcy8
prerank,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,-0.5321801331183802,-0.8639822898122168,0.6897001303780965,0.9508234508915613,1.0,4/20,15.35%,Pigk;Pigyl;Pigf;Dpm2
prerank,Retrograde endocannabinoid signaling,-0.45578141964773916,-0.8529949266232517,0.7715196599362381,0.9643646556873559,1.0,26/108,14.24%,Kcnj3;Ndufa3;Ndufa1;Ndufs8;Ndufs5;Gnb2;Ndufs2;Ndufa2;Ndufs7;Ndufa4;Ndufb3;Ndufb11;Ndufb10;Gabrg2;Gng2;Ndufa13;Gng13;Gng10;Ndufb8;Ndufa8;Ndufa7;Ndufv1;Ndufc2;Gng3;Ndufv2;Gnai2
prerank,PPAR signaling pathway,-0.5070073911011109,-0.8477948503671305,0.7289603960396039,0.9675971531094617,1.0,7/29,14.29%,Acsl3;Scp2;Fabp5;Dbi;Fabp7;Ilk;Fabp3
prerank,Pyruvate metabolism,-0.5107090689825996,-0.8412074888019834,0.743558282208589,0.9726415408049163,1.0,7/27,11.72%,Mdh2;Pkm;Mdh1;Glo1;Ldha;Hagh;Dlat
prerank,Dilated cardiomyopathy (DCM),-0.48598933067935013,-0.8396893788469735,0.7409568261376897,0.9691543275426473,1.0,3/49,1.87%,Actb;Gnas;Actg1
prerank,Homologous recombination,-0.5030154766020649,-0.8249981167685014,0.7404092071611253,0.9873376978741575,1.0,2/21,8.11%,Sem1;Rpa3
prerank,Adipocytokine signaling pathway,-0.4817108636548834,-0.8249285701213225,0.7672209026128266,0.981516303964866,1.0,5/39,9.99%,Acsl3;Agrp;Nfkbib;G6pc3;Irs2
prerank,Notch signaling pathway,-0.4866811984996824,-0.8246363467617439,0.7777777777777778,0.9761356427895244,1.0,4/35,13.14%,Snw1;Psenen;Aph1a;Jag1
prerank,Hepatitis B,-0.4469451311622344,-0.8243317153269784,0.7945945945945946,0.9706822215982905,1.0,16/90,18.37%,Jun;Ywhab;Bax;Cycs;Pcna;Bad;Kras;Ywhaq;Vdac3;Hras;Ywhaz;Pik3r1;Ddb2;Smad2;Mapk3;Egr3
prerank,Small cell lung cancer,0.35304860219650475,0.819996351468321,0.7622950819672131,1.0,1.0,9/50,11.09%,Rarb;Chuk;Lamb1;Traf3;Akt2;Lamc1;Ikbkb;Pik3r3;Polk
prerank,Serotonergic synapse,-0.4629191926390805,-0.8175230135011905,0.7852272727272728,0.975517437159128,1.0,10/57,14.24%,Kcnj3;Gnas;Gnb2;Gng2;Gng13;Gng10;Kras;Hras;Gng3;Gnai2
prerank,Ubiquitin mediated proteolysis,0.3284643463721553,0.8168186228230292,0.8333333333333334,1.0,1.0,12/116,6.12%,Ubr5;Ube2e2;Prkn;Cdc27;Huwe1;Trip12;Herc2;Birc6;Herc1;Ube3c;Ube4a;Cbl
prerank,Toxoplasmosis,-0.46759348329261535,-0.8155061519352357,0.7899543378995434,0.9728829567489444,1.0,7/51,9.72%,Hspa8;Hspa2;Nfkbib;Cycs;Bad;Ifngr2;Ldlr
prerank,Lysine degradation,0.38349068198374936,0.8088538144781012,0.7828947368421053,1.0,1.0,11/43,17.39%,Ehmt1;Colgalt2;Acat1;Kmt2a;Setdb1;Kmt2b;Ehmt2;Nsd1;Kmt2c;Nsd3;Kmt5b
prerank,RIG-I-like receptor signaling pathway,0.38271105749907863,0.8070292876970413,0.766497461928934,1.0,1.0,6/26,9.93%,Chuk;Mapk14;Traf3;Mapk10;Map3k7;Ikbkb
prerank,Hypertrophic cardiomyopathy (HCM),-0.4600894310123154,-0.7934958330541816,0.803030303030303,0.998494799841941,1.0,2/43,1.87%,Actb;Actg1
prerank,Breast cancer,-0.43475285256316826,-0.7848927609917263,0.8391451068616423,1.0,1.0,13/72,17.95%,Jun;Nfkb2;Bax;Cdk4;Fgfr1;Kras;Hras;Jag1;Fzd3;Hey1;Pik3r1;Ddb2;Mapk3
prerank,Arrhythmogenic right ventricular cardiomyopathy (ARVC),-0.4540105030767902,-0.7847784392430918,0.8182870370370371,0.9992613956966858,1.0,7/46,11.66%,Actb;Actg1;Ctnna3;Emd;Gja1;Itgav;Ctnna1
prerank,Amoebiasis,-0.4520546511827196,-0.7822381177672129,0.8052256532066508,0.9967864970849066,1.0,1/35,1.47%,Gnas
prerank,Butanoate metabolism,-0.49955215614487536,-0.7796920980531383,0.7976031957390146,0.9943627252697049,1.0,1/15,7.85%,Hmgcs1
prerank,TGF-beta signaling pathway,-0.441350130497429,-0.7755575874623114,0.8253223915592028,0.9942036731880977,1.0,11/46,18.49%,Ppp2r1a;Bambi;Inhba;Rbx1;Ppp2ca;Bmpr1b;Smad7;Id2;Smad2;Mapk3;E2f4
prerank,Ovarian steroidogenesis,-0.48448030372318474,-0.7721865053517585,0.7997432605905006,0.9932108052511021,1.0,2/18,9.72%,Gnas;Ldlr
prerank,Central carbon metabolism in cancer,-0.43683955912417693,-0.7707854260876321,0.8261877172653534,0.989466850224463,1.0,12/44,17.95%,Pgam1;Pkm;Fgfr2;Sco2;Ldha;Fgfr1;Kras;Hras;Sirt6;Pfkl;Pik3r1;Mapk3
prerank,Gastric cancer,0.32812131792408034,0.760135188364083,0.9391304347826087,1.0,1.0,11/72,11.09%,Fgf10;Rarb;Tgfbr1;Raf1;Apc;Abcb1b;Akt2;Axin1;Sos1;Pik3r3;Polk
prerank,Circadian rhythm,-0.45405571329304356,-0.757214725436963,0.8156565656565656,1.0,1.0,3/26,10.97%,Csnk1e;Rorb;Rbx1
prerank,Th1 and Th2 cell differentiation,-0.4468490784271065,-0.7515301879488447,0.8461538461538461,1.0,1.0,7/32,14.45%,Jun;Nfkbib;Ppp3ca;Ifngr2;Ppp3r1;Jag1;Ppp3cb
prerank,AMPK signaling pathway,-0.4103488640442436,-0.7481290611247539,0.8870614035087719,1.0,1.0,13/85,17.47%,Rab2a;Eef2;Rheb;G6pc3;Ppp2r1a;Irs2;Ppp2ca;Rab14;Pfkl;Ppp2r5d;Pik3r1;Akt1s1;Hmgcr
prerank,Axon guidance,-0.3981698940808107,-0.7476867515885618,0.9050160085378869,0.9956855985161329,1.0,20/127,14.45%,Epha5;Rac1;Ntng1;Cfl1;Epha7;Lrrc4;Nck1;Cdc42;Ppp3ca;Cfl2;Myl12b;Kras;Ppp3r1;Dpysl2;Hras;Ilk;Sema5a;Fzd3;Gnai2;Ppp3cb
prerank,Chronic myeloid leukemia,0.3253064560293853,0.7450431786405285,0.9009009009009009,1.0,1.0,12/56,11.09%,Chuk;Tgfbr1;Bcr;Raf1;Cbl;Gab2;Akt2;Hdac1;Ikbkb;Sos1;Pik3r3;Polk
prerank,Fc epsilon RI signaling pathway,-0.4222166181625678,-0.7331772107622436,0.8524203069657615,1.0,1.0,6/37,17.95%,Rac1;Kras;Lyn;Hras;Pik3r1;Mapk3
prerank,Sphingolipid signaling pathway,-0.40219796527539864,-0.7298804249106519,0.8815642458100559,1.0,1.0,12/80,17.95%,Rac1;Bax;Ppp2r1a;Ppp2ca;Kras;Nsmaf;Hras;Gnai2;Ppp2r5d;Gnai1;Pik3r1;Mapk3
prerank,Hedgehog signaling pathway,0.34032731582063674,0.7282347578768438,0.8901098901098901,1.0,1.0,7/31,11.12%,Csnk1g1;Sufu;Grk3;Cdon;Evc2;Ccnd2;Smo
prerank,Melanoma,-0.4187531726284558,-0.7204689339390685,0.8810939357907254,1.0,1.0,11/41,17.95%,Bax;Bad;Pdgfa;Cdk4;Fgfr1;Kras;Hras;Pik3r1;Ddb2;Pdgfb;Mapk3
prerank,Longevity regulating pathway,-0.3956253840143388,-0.7191963241925279,0.9095920617420066,1.0,1.0,13/80,16.69%,Hspa8;Sesn1;Bax;Hspa2;Rheb;Sod1;Irs2;Kras;Hras;Cryab;Eif4ebp2;Pik3r1;Akt1s1
prerank,Mannose type O-glycan biosynthesis,0.35578803974558415,0.7030198043370482,0.9082969432314411,1.0,1.0,5/20,18.08%,Mgat5b;St3gal3;Chst10;B3galnt2;Large1
prerank,"Alanine, aspartate and glutamate metabolism",0.3567590618492116,0.702962265913301,0.8916256157635468,1.0,1.0,2/22,8.55%,Rimkla;Rimklb
prerank,MAPK signaling pathway,-0.37035226618911943,-0.7016567378947004,0.9664921465968587,1.0,1.0,24/177,12.78%,Rac1;Jun;Rasgrp1;Nfkb2;Hspa8;Vegfc;Dusp3;Jund;Dusp7;Hspa2;Fgfr2;Bdnf;Cdc42;Ppp3ca;Lamtor3;Pdgfa;Angpt2;Tek;Vegfb;Fgfr1;Kras;Ppp3r1;Stmn1;Hras
prerank,Basal transcription factors,-0.41243665920245576,-0.7011216046769511,0.8847980997624703,1.0,1.0,8/34,23.31%,Taf10;Taf11;Tbpl1;Gtf2b;Taf5;Gtf2h5;Ercc3;Gtf2h4
prerank,Choline metabolism in cancer,-0.3857536846612624,-0.699470146678854,0.9272116461366181,1.0,1.0,5/73,7.77%,Rac1;Jun;Rheb;Wasl;Pdgfa
prerank,GABAergic synapse,-0.3903392468097454,-0.6989602194363513,0.9137931034482759,1.0,1.0,13/64,14.24%,Gabarapl1;Gnb2;Gabarapl2;Gabarap;Glul;Gabrg2;Gng2;Gng13;Gng10;Plcl1;Slc38a2;Gng3;Gnai2
prerank,Amino sugar and nucleotide sugar metabolism,0.3425091003564675,0.6973706382839049,0.9285714285714286,1.0,1.0,1/28,0.43%,Gck
prerank,Acute myeloid leukemia,0.31516525466300993,0.6955616727637057,0.9294871794871795,0.9930012107610076,1.0,9/41,11.18%,Chuk;Flt3;Raf1;Runx1t1;Akt2;Ikbkb;Sos1;Pik3r3;Ppard
prerank,TNF signaling pathway,-0.39063535462967786,-0.6937356243461732,0.9177142857142857,1.0,1.0,13/53,24.27%,Jun;Junb;Jag1;Cebpb;Bag4;Pik3r1;Mapk3;Cx3cl1;Cflar;Rela;Atf2;Akt1;Creb3
prerank,Non-small cell lung cancer,0.2983709336089572,0.6756535055312262,0.9857142857142858,0.9803441496439754,1.0,9/49,11.09%,Rarb;Prkcg;Raf1;Plcg2;Akt2;Eml4;Sos1;Pik3r3;Polk
prerank,ErbB signaling pathway,-0.3746645019393657,-0.6734941277598366,0.9313063063063063,1.0,1.0,7/68,14.44%,Jun;Nrg4;Nck1;Bad;Kras;Hras;Cdkn1b
prerank,Signaling pathways regulating pluripotency of stem cells,-0.36715726456201725,-0.6690905095546342,0.9541899441340782,1.0,1.0,12/70,17.95%,Fgfr2;Skil;Inhba;Fgfr1;Kras;Hras;Fzd3;Bmpr1b;Pik3r1;Id2;Smad2;Mapk3
prerank,Ether lipid metabolism,-0.4079771407626329,-0.6677481125617211,0.8807692307692307,1.0,1.0,4/21,18.85%,Pla2g7;Pafah1b2;Pafah1b1;Plpp3
prerank,Bladder cancer,-0.39813814200050174,-0.6615141712371684,0.9051833122629582,1.0,1.0,4/23,17.95%,Cdk4;Kras;Hras;Mapk3
prerank,NF-kappa B signaling pathway,-0.37786080024078195,-0.6550984538866522,0.9314420803782506,1.0,1.0,4/36,14.47%,Nfkb2;Csnk2b;Lyn;Parp1
prerank,Cortisol synthesis and secretion,-0.38119886998167624,-0.6550163845822013,0.926829268292683,1.0,1.0,4/38,9.72%,Gnas;Nceh1;Kcnk2;Ldlr
prerank,Cytokine-cytokine receptor interaction,-0.3700425229984824,-0.6474043648362222,0.9388489208633094,1.0,1.0,6/44,15.47%,Il18;Ccl27a;Ifngr2;Inhba;Csf1r;Bmpr1b
prerank,MicroRNAs in cancer,-0.35020148624549896,-0.6469415468077631,0.9710789766407119,1.0,1.0,11/86,14.44%,Timp3;Spry2;Pdgfa;Irs2;Tpm1;Marcks;Kras;Stmn1;Hras;Fzd3;Cdkn1b
prerank,Tryptophan metabolism,0.33165952864059967,0.6424555485183105,0.9253112033195021,0.9717981277500517,1.0,1/16,7.31%,Acat1
prerank,Herpes simplex virus 1 infection,-0.3330990818709999,-0.6356496802470545,0.9927760577915377,1.0,1.0,26/198,19.92%,Calr;Bax;Ppp1ca;Rheb;Pml;Cycs;Bad;Zfp868;Pdia3;Ifngr2;Zfp763;Zfp235;Zfp46;Zfp273;Zfp867;Zfp799;Zfp212;A430033K04Rik;Pik3r1;Eif2b5;Zfp560;Hcfc1;Srsf3;Zfp39;Zfp12;Irf3
prerank,Cholinergic synapse,-0.3484692300053466,-0.6345616797305436,0.9668141592920354,0.998711643626379,1.0,16/74,18.54%,Kcnj3;Gnb2;Kcnj2;Gng2;Gng13;Gng10;Kcnj4;Kras;Hras;Gng3;Gnai2;Gnai1;Pik3r1;Gna11;Mapk3;Chrnb2
prerank,Cushing syndrome,-0.3427984946982984,-0.6326693334232657,0.9735391400220507,0.9948806617766618,1.0,13/85,17.95%,Gnas;Nceh1;Kcnk2;Cdk4;Ldlr;Aip;Fzd3;Gnai2;Cdkn1b;Kcna4;Gnai1;Gna11;Mapk3
prerank,Phospholipase D signaling pathway,-0.3354064170409518,-0.6161188207113552,0.9857612267250822,0.9994169649258373,1.0,6/93,7.77%,Gnas;Arf1;Grm3;Rheb;Cyth2;Pdgfa
prerank,Cell adhesion molecules (CAMs),-0.35049635125370093,-0.6142620559555755,0.9664739884393063,0.9955710966151213,1.0,4/51,10.80%,Ntng1;Lrrc4;Ncam2;Itgav
prerank,Basal cell carcinoma,-0.37143308404035447,-0.6005478356411778,0.9665809768637532,0.9974517205210027,1.0,3/21,17.22%,Bax;Fzd3;Ddb2
prerank,Aminoacyl-tRNA biosynthesis,-0.34406980300930906,-0.5930538656537823,0.9752941176470589,0.9957338973173812,1.0,9/39,28.47%,Nars;Aars;Gatb;Wars2;Tarsl2;Tars;Gatc;Yars2;Fars2
prerank,Fanconi anemia pathway,-0.35058675852305454,-0.5870584774393517,0.9710843373493976,0.9931829842132665,1.0,1/29,8.11%,Rpa3
prerank,N-Glycan biosynthesis,-0.32241320763911496,-0.5660142636214253,0.984759671746776,0.995427525120059,1.0,3/43,9.40%,Dpm3;Ddost;Dad1
prerank,Inositol phosphate metabolism,-0.29090336012982176,-0.5187066464660881,0.9988545246277205,0.9997305699382766,1.0,8/51,19.90%,Aldh6a1;Tpi1;Cdipt;Inpp5f;Pip4k2a;Impa1;Itpka;Inpp4b
prerank,JAK-STAT signaling pathway,-0.29077586998352706,-0.517226835397055,0.9965831435079726,0.9951650589853286,1.0,7/58,17.59%,Pdgfa;Ifngr2;Hras;Ccnd3;Pik3r1;Stam2;Pdgfb
